Total Payments
$350,670
2024 Payments
$332.75
Companies
17
Transactions
130
Medicare Patients
860
Medicare Billing
$131,159

Payment Breakdown by Category

Consulting$307,962 (87.8%)
Other$33,345 (9.5%)
Research$4,810 (1.4%)
Travel$2,541 (0.7%)
Food & Beverage$1,923 (0.5%)
Education$89.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $307,962 70 87.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $33,345 13 9.5%
Unspecified $4,810 5 1.4%
Travel and Lodging $2,541 8 0.7%
Food and Beverage $1,923 33 0.5%
Education $89.00 1 0.0%

Payments by Type

General
$345,860
125 transactions
Research
$4,810
5 transactions

Top Paying Companies

Company Total Records Latest Year
Foundation Medicine, Inc. $340,991 92 $0 (2023)
F. Hoffmann-La Roche AG $4,546 4 $0 (2022)
Bayer Healthcare Pharmaceuticals Inc. $3,060 3 $0 (2023)
Merck Sharp & Dohme Corporation $817.72 10 $0 (2019)
Eli Lilly and Company $264.40 1 $0 (2019)
Boston Scientific Corporation $144.37 1 $0 (2024)
Sirtex Medical Inc $137.02 1 $0 (2018)
E.R. Squibb & Sons, L.L.C. $135.62 7 $0 (2020)
Tempus AI, Inc $122.32 1 $0 (2024)
Regeneron Healthcare Solutions, Inc. $111.59 3 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $332.75 3 Boston Scientific Corporation ($144.37)
2023 $34,114 17 Foundation Medicine, Inc. ($33,345)
2022 $59,762 16 Foundation Medicine, Inc. ($55,217)
2021 $77,915 15 Foundation Medicine, Inc. ($76,250)
2020 $119,436 26 Foundation Medicine, Inc. ($119,397)
2019 $42,109 30 Foundation Medicine, Inc. ($40,121)
2018 $13,785 13 Foundation Medicine, Inc. ($13,613)
2017 $3,217 10 Foundation Medicine, Inc. ($3,050)

All Payment Transactions

130 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
09/30/2024 Alimera Sciences, Inc. YUTIQ (Drug), ILUVIEN Food and Beverage In-kind items and services $66.06 General
Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye
09/25/2024 Tempus AI, Inc XT CDX (Device) Food and Beverage In-kind items and services $122.32 General
Category: NONE
07/30/2024 Boston Scientific Corporation TheraSphere Y90 Glass Microspheres 10 GBq (Device) Food and Beverage In-kind items and services $144.37 General
Category: TheraSphere_PI
12/19/2023 Foundation Medicine, Inc. FOUNDATIONONE CDX (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,340.00 General
Category: Oncology
12/08/2023 Foundation Medicine, Inc. FOUNDATIONONE CDX (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,340.00 General
Category: Oncology
11/22/2023 Foundation Medicine, Inc. FOUNDATIONONE CDX (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,340.00 General
Category: Oncology
10/24/2023 Bayer Healthcare Pharmaceuticals Inc. Vitrakvi (Drug) Consulting Fee Cash or cash equivalent $657.00 General
Category: Oncology
10/16/2023 Foundation Medicine, Inc. FOUNDATIONONE CDX (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,340.00 General
Category: Oncology
09/12/2023 Foundation Medicine, Inc. FOUNDATIONONE CDX (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,340.00 General
Category: Oncology
08/25/2023 Foundation Medicine, Inc. FOUNDATIONONE CDX (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,680.00 General
Category: Oncology
07/19/2023 Foundation Medicine, Inc. FOUNDATIONONE CDX (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,340.00 General
Category: Oncology
06/13/2023 Foundation Medicine, Inc. FOUNDATIONONE CDX (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $585.00 General
Category: Oncology
05/17/2023 Foundation Medicine, Inc. FOUNDATIONONE CDX (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,095.00 General
Category: Oncology
05/03/2023 Regeneron Healthcare Solutions, Inc. EYLEA (Biological) Food and Beverage In-kind items and services $37.01 General
Category: OPHTHALMOLOGY
04/13/2023 Foundation Medicine, Inc. FOUNDATIONONE CDX (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,340.00 General
Category: Oncology
04/05/2023 Regeneron Healthcare Solutions, Inc. EYLEA (Biological) Food and Beverage In-kind items and services $34.46 General
Category: OPHTHALMOLOGY
03/08/2023 Foundation Medicine, Inc. FOUNDATIONONE CDX (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,680.00 General
Category: Oncology
02/20/2023 Foundation Medicine, Inc. FOUNDATIONONE CDX (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $585.00 General
Category: Oncology
02/14/2023 Foundation Medicine, Inc. FOUNDATIONONE CDX (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,340.00 General
Category: Oncology
02/08/2023 Regeneron Healthcare Solutions, Inc. EYLEA (Biological) Food and Beverage In-kind items and services $40.12 General
Category: OPHTHALMOLOGY
12/31/2022 F. Hoffmann-La Roche AG In-kind items and services $1,164.67 Research
Study: PAN-TUMOR LANDSCAPE OF FIBROBLAST GROWTH FACTOR RECEPTOR 1-4 GENOMIC ALTERATIONS
12/31/2022 F. Hoffmann-La Roche AG In-kind items and services $981.13 Research
Study: CO-MUTATIONAL LANDSCAPE OF KEY FIBROBLAST GROWTH FACTOR RECEPTOR FGFR ALTERATIONS IN INTRA-HEPATIC CHOLANGIOCARCINOMA ICCA, BLADDER CANCER BC AND GLIOMA
12/28/2022 Foundation Medicine, Inc. FOUNDATIONONE CDX (Device) Consulting Fee Cash or cash equivalent $5,674.50 General
Category: ONCOLOGY
12/28/2022 Foundation Medicine, Inc. FOUNDATIONONE CDX (Device) Consulting Fee Cash or cash equivalent $877.50 General
Category: ONCOLOGY
12/14/2022 Foundation Medicine, Inc. FOUNDATIONONE CDX (Device) Consulting Fee Cash or cash equivalent $1,579.50 General
Category: Oncology

Research Studies & Clinical Trials

Study Name Company Amount Records
PAN-TUMOR GENOMIC ALTERATION LANDSCAPE OF FGFR1-4 F. Hoffmann-La Roche AG $1,908 1
PAN-TUMOR LANDSCAPE OF FIBROBLAST GROWTH FACTOR RECEPTOR 1-4 GENOMIC ALTERATIONS F. Hoffmann-La Roche AG $1,165 1
CO-MUTATIONAL LANDSCAPE OF KEY FIBROBLAST GROWTH FACTOR RECEPTOR FGFR ALTERATIONS IN INTRA-HEPATIC CHOLANGIOCARCINOMA ICCA, BLADDER CANCER BC AND GLIOMA F. Hoffmann-La Roche AG $981.13 1
CO-MUTATIONAL LANDSCAPE OF KEY FIBROBLAST GROWTH FACTOR RECEPTOR FGFR ALTERATIONS IN INTRA-HEPATIC CHOLANGIOCARCINOMA ICCA, BLADDER CANCER BC, GLIOMA F. Hoffmann-La Roche AG $491.53 1
RANDOMIZED STUDY OF AM0010 IN COMBINATION WITH FOLFOX COMPARED TO FOLFOX ALONE AS SECOND-LINE TX IN PTS WITH META PANCREATIC CANCER THAT HAS PROGRESSED DURING OR FOLLOWING A FIRST-LINE GEMCITABINE CONTAINING REGIMEN Eli Lilly and Company $264.40 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 249 444 $121,717 $39,105
2022 7 220 408 $103,715 $36,663
2021 3 110 179 $88,014 $18,763
2020 6 281 561 $241,495 $36,628
Total Patients
860
Total Services
1,592
Medicare Billing
$131,159
Procedure Codes
24

All Medicare Procedures & Services

24 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 55 226 $62,150 $16,604 26.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 36 49 $17,150 $5,475 31.9%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 51 52 $12,702 $5,415 42.6%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 35 35 $14,875 $4,848 32.6%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 43 52 $6,760 $3,309 48.9%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 14 14 $5,040 $1,991 39.5%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 15 16 $3,040 $1,464 48.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 50 201 $52,715 $17,308 32.8%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 34 34 $13,925 $5,040 36.2%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 35 37 $8,990 $4,210 46.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 20 26 $8,650 $3,286 38.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 37 60 $10,180 $3,238 31.8%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 33 39 $5,070 $2,281 45.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 11 11 $4,185 $1,301 31.1%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 57 93 $55,242 $10,595 19.2%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 22 52 $21,892 $3,588 16.4%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 19 19 $7,325 $3,132 42.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 12 15 $3,555 $1,449 40.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 98 233 $98,093 $14,450 14.7%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 57 104 $61,776 $9,629 15.6%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 70 168 $45,864 $6,673 14.6%
99205 New patient office or other outpatient visit, typically 60 minutes Facility 2020 29 29 $26,216 $3,908 14.9%
99204 New patient office or other outpatient visit, typically 45 minutes Facility 2020 12 12 $8,316 $1,297 15.6%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Facility 2020 15 15 $1,230 $669.91 54.5%

About Dr. Ankur Parikh, D.O

Dr. Ankur Parikh, D.O is a Student in an Organized Health Care Education/Training Program healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2008. The National Provider Identifier (NPI) number assigned to this provider is 1245499144.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ankur Parikh, D.O has received a total of $350,670 in payments from pharmaceutical and medical device companies, with $332.75 received in 2024. These payments were reported across 130 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($307,962).

As a Medicare-enrolled provider, Parikh has provided services to 860 Medicare beneficiaries, totaling 1,592 services with total Medicare billing of $131,159. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.

Practice Information

Products in Payments

  • FOUNDATIONONE CDX (Device) $204,062
  • FOUNDATIONONE LIQUID (Device) $127,986
  • FOUNDATIONACT (Device) $8,870
  • Vitrakvi (Drug) $2,300
  • MK-7339 (Drug) $817.72
  • Stivarga (Drug) $760.00
  • TheraSphere Y90 Glass Microspheres 10 GBq (Device) $144.37
  • SIR-Spheres Microspheres (Device) $137.02
  • XT CDX (Device) $122.32
  • EYLEA (Biological) $111.59
  • XOSPATA (Drug) $105.58
  • OPDIVO (Biological) $91.09
  • XTANDI (Drug) $89.00
  • FOUNDATIONONE (Device) $73.69
  • YUTIQ (Drug) $66.06
  • BRAFTOVI (Drug) $22.36
  • EMPLICITI (Biological) $21.82
  • Xermelo (Drug) $21.74
  • Smoflipid (Drug) $16.95

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Philadelphia